Perspectives

Operating under a Consent Decree

Managing a Life Sciences company through a major regulatory action

Through planning and commitment, your company can mitigate the near-term disruptions caused by a Consent Decree and eventually emerge as a stronger, more compliant, and quality conscious company, well-positioned for long-term success.

Download PDF

Learn more about operating under Consent Decree

Tarnished reputations, lost sales, massive fines & remediation expenses, cultural change and hostile working environments, diminished morale, legal disputes, employee retention, and product shortages are common challenges faced by Life Sciences companies operating under Consent Decrees (CD). There is no aspect of the business that is unaffected, and the impacts can extend to customers and patients as well. It takes a broad-based effort to effectively address the concerns of regulatory agencies while simultaneously preparing the company to manage its current business as well as their mid- and long-term operations. The effort involved goes well beyond simply developing and executing a remediation plan and should consider the strategies and tactics to design and manage an organization that not only has to survive as the remediation efforts are underway, but also thrive in the future.

Meet the authors

Joe Slota

Joe Slota

Product & Supply Operations Leader | Life Sciences

Joe is a director in Deloitte Consulting LLP’s Lif...More

Greg Reh

Greg Reh

DTTL Global Life Sciences Sector Leader

Greg is the DTTL Global Life Sciences Sector Leade...More

Contact us

Contact us via our online form

Submit RFP

Submit via our online form

Find an office

Find a local office